Company intelligence / Profile preview

Increas

Zug, Zug, Switzerland

Ownership: Private
Development stage: Other

Overview

Increas is a global pharmaceutical company focused on developing and commercializing Value-Added Medicines (VAMs) to address unmet medical needs in chronic diseases. The company leverages established molecules and innovative delivery technologies to improve patient outcomes, adherence, and access to essential therapies. Headquartered in Switzerland with a significant presence in Brazil, Increas targets high-growth markets and therapeutic areas such as metabolic disorders, cardiovascular health, and renal diseases. Their pipeline includes optimized formulations of widely used drugs, designed to offer superior efficacy or safety profiles compared to standard treatments.

Therapeutic areas: EndocrinologyCardiovascularNephrology
Modalities: Small moleculeBiologicPeptide
Industry: Biotech

Beyond the preview

Go deeper on Increas.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Increas.

Explore the full profile